GEICAM is the leading group in breast cancer research in Spain and is also internationally recognized. It is integrated by almost 800 experts working in 184 hospitals through Spain.
One of its main goals is to promote independent clinical, epidemiological and translational research in breast cancer treatment, as well as to provide medical education for professionals and information to those affected by the disease and to promote their participation in clinical trials.
Since its establishment in 1995, GEICAM has conducted over a hundred studies with more than 46.000 participants.
We use own and third party cookies to improve our service, navigation for our website. We analyze your navigation. If you continue in our website, you accept this use. You can obtain more information or you know how to change configuration in our cookies policy.I agreeMore info